However, the 2012 KDIGO Clinical Practice Guideline for AKI [3] and a 2013 Cochrane review [159] carefully assessed individual pieces of evidence, and lead to a revised conclusion that there is insufficient evidence to declare that low-dose ANP is effective for treatment or prevention of AKI. Here, NPPA is linked to acute kidney injury.